LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease
Aim. To explore the expression of long noncoding RNA (LncRNA) LUCAT1 in adult patients with Crohn’s disease (CD) and evaluate the relationship between LncRNA LUCAT1 and the disease activity in Chinese patients with CD. Methods. Patients with CD and healthy participants (≥18 years old) were enrolled...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2021/5557357 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850159676899983360 |
|---|---|
| author | Xiao-yi Kuai Shun-ying Yu Xiu-fang Cui Xiao-jing Zhao Xia-qiong Mao Yang Yu Tong Hu Hong-jie Zhang Chun-li Zhou |
| author_facet | Xiao-yi Kuai Shun-ying Yu Xiu-fang Cui Xiao-jing Zhao Xia-qiong Mao Yang Yu Tong Hu Hong-jie Zhang Chun-li Zhou |
| author_sort | Xiao-yi Kuai |
| collection | DOAJ |
| description | Aim. To explore the expression of long noncoding RNA (LncRNA) LUCAT1 in adult patients with Crohn’s disease (CD) and evaluate the relationship between LncRNA LUCAT1 and the disease activity in Chinese patients with CD. Methods. Patients with CD and healthy participants (≥18 years old) were enrolled in this study between January 2018 and December 2019. The expression of LncRNA LUCAT1 in plasma samples was evaluated by quantitative reverse transcription-polymerase chain reaction. Basic characteristics of patients with CD were collected, including gender, age, clinical stage, disease behavior, disease location, C-reactive protein (CRP), platelet (PLT), erythrocyte sedimentation rate (ESR), fecal calprotectin (FC), Crohn’s disease activity index (CDAI) score, and simplified Crohn’s disease endoscopic score (SES-CD). Results. In total, 168 patients with CD and 65 healthy participants (≥18 years old) were enrolled in this study. Among them, ninety patients with clinically active CD, seventy-eight patients with CD in clinical remission, forty-eight patients with endoscopically active CD, thirty patients with endoscopically inactive CD, and sixty-five healthy participants. LncRNA LUCAT1 was increased in plasma of patients with CD compared with the control group. The plasma LncRNA LUCAT1 level of patients with CD both in the clinical and endoscopic active phase was higher than that of both the clinical and endoscopic remission phase. The plasma level of LncRNA LUCAT1 in patients with CD was positively correlated with ESR, CRP, FC, CDAI, and SES-CD. There was no significant correlation between the level of LUCAT1 and platelets. The plasma LncRNA LUCAT1 level in patients with CD had significant differences between severe active patients and mild/moderate active patients. Conclusion. The plasma LncRNA LUCAT1 is positively associated with the disease activity in patients with CD, and it may act as a noninvasive biomarker to identify the degree of disease activity. |
| format | Article |
| id | doaj-art-b328c3993f7c4da09befddf413ca295f |
| institution | OA Journals |
| issn | 1687-6121 1687-630X |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-b328c3993f7c4da09befddf413ca295f2025-08-20T02:23:27ZengWileyGastroenterology Research and Practice1687-61211687-630X2021-01-01202110.1155/2021/55573575557357LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s DiseaseXiao-yi Kuai0Shun-ying Yu1Xiu-fang Cui2Xiao-jing Zhao3Xia-qiong Mao4Yang Yu5Tong Hu6Hong-jie Zhang7Chun-li Zhou8Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, No. 242, Guangji Road, Suzhou, 215008 Jiangsu Province, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029 Jiangsu Province, ChinaDepartment of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, No. 242, Guangji Road, Suzhou, 215008 Jiangsu Province, ChinaAim. To explore the expression of long noncoding RNA (LncRNA) LUCAT1 in adult patients with Crohn’s disease (CD) and evaluate the relationship between LncRNA LUCAT1 and the disease activity in Chinese patients with CD. Methods. Patients with CD and healthy participants (≥18 years old) were enrolled in this study between January 2018 and December 2019. The expression of LncRNA LUCAT1 in plasma samples was evaluated by quantitative reverse transcription-polymerase chain reaction. Basic characteristics of patients with CD were collected, including gender, age, clinical stage, disease behavior, disease location, C-reactive protein (CRP), platelet (PLT), erythrocyte sedimentation rate (ESR), fecal calprotectin (FC), Crohn’s disease activity index (CDAI) score, and simplified Crohn’s disease endoscopic score (SES-CD). Results. In total, 168 patients with CD and 65 healthy participants (≥18 years old) were enrolled in this study. Among them, ninety patients with clinically active CD, seventy-eight patients with CD in clinical remission, forty-eight patients with endoscopically active CD, thirty patients with endoscopically inactive CD, and sixty-five healthy participants. LncRNA LUCAT1 was increased in plasma of patients with CD compared with the control group. The plasma LncRNA LUCAT1 level of patients with CD both in the clinical and endoscopic active phase was higher than that of both the clinical and endoscopic remission phase. The plasma level of LncRNA LUCAT1 in patients with CD was positively correlated with ESR, CRP, FC, CDAI, and SES-CD. There was no significant correlation between the level of LUCAT1 and platelets. The plasma LncRNA LUCAT1 level in patients with CD had significant differences between severe active patients and mild/moderate active patients. Conclusion. The plasma LncRNA LUCAT1 is positively associated with the disease activity in patients with CD, and it may act as a noninvasive biomarker to identify the degree of disease activity.http://dx.doi.org/10.1155/2021/5557357 |
| spellingShingle | Xiao-yi Kuai Shun-ying Yu Xiu-fang Cui Xiao-jing Zhao Xia-qiong Mao Yang Yu Tong Hu Hong-jie Zhang Chun-li Zhou LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease Gastroenterology Research and Practice |
| title | LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease |
| title_full | LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease |
| title_fullStr | LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease |
| title_full_unstemmed | LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease |
| title_short | LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease |
| title_sort | lncrna lucat1 as a plasma biomarker for assessing disease activity in adult patients with crohn s disease |
| url | http://dx.doi.org/10.1155/2021/5557357 |
| work_keys_str_mv | AT xiaoyikuai lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT shunyingyu lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT xiufangcui lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT xiaojingzhao lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT xiaqiongmao lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT yangyu lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT tonghu lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT hongjiezhang lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease AT chunlizhou lncrnalucat1asaplasmabiomarkerforassessingdiseaseactivityinadultpatientswithcrohnsdisease |